Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Novel preclinical model for cancer cachexia

Dec. 30, 2015

PI3Kdelta inhibitors revealed in Merck & Co. patent

Dec. 29, 2015

Biosimilar adalimumab M-923 met primary endpoint in pharmacokinetic study

Dec. 24, 2015

Cell therapy improves functional and structural outcome after muscle trauma

Dec. 23, 2015

Galapagos and Gilead Sciences partner to develop filgotinib for inflammatory diseases

Dec. 17, 2015

TEI-SARM2 shows promise for the treatment of muscle wasting diseases

Dec. 11, 2015

FDA decides to review Anika's Cingal as drug rather than device

Dec. 11, 2015

Morphotek reports phase I data from MORAb-022-001 trial

Dec. 11, 2015

Novartis initiates first-in-human trial of LNA-043

Dec. 11, 2015

R-Pharm begins global phase III trial program for olokizumab

Dec. 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...